NeuroSense Therapeutics L... (NRSNW)
NASDAQ: NRSNW
· Real-Time Price · USD
0.69
0.00 (0.00%)
At close: Aug 15, 2025, 3:20 PM
0.75
8.70%
After-hours: Aug 15, 2025, 04:00 PM EDT
NeuroSense Therapeutics Fail-to-Deliver
Total FTD Shares
466
Below Average
FTD / Avg. Volume
6.12%
Low Impact
1-Year Change
-90.5%
Negative Trend
FTD Chart
As of Jun 2, 2025,
NeuroSense Therapeutics Ltd. has
466
shares failed to deliver, representing 6.12%
of the average daily volume of
7,611.207
shares. Over the past year, the monthly average FTD is
923
shares, with the current level 50% below
the historical average, indicating
moderate
settlement pressure. The weighted FTD ratio above 1% suggests potential liquidity constraints or heightened short-selling activity.
FTD History
| Date | Price | FTD Shares | % Change |
|---|---|---|---|
| Jun 02, 2025 | 0.44 | 466 | n/a |
| May 30, 2025 | 0.484 | 466 | +1453.33% |
| Apr 16, 2025 | 0.20 | 30 | -95.41% |
| Mar 25, 2025 | 0.22 | 653 | -30.09% |
| Feb 21, 2025 | 0.23 | 934 | +1234.29% |
| Jan 31, 2025 | 0.23 | 70 | -88.69% |
| Dec 23, 2024 | 0.45 | 619 | +304.58% |
| Nov 29, 2024 | 0.241 | 153 | +194.23% |
| Oct 31, 2024 | 0.1777 | 52 | -92.67% |
| Sep 25, 2024 | 0.17 | 709 | +4626.67% |
| Aug 02, 2024 | 0.15 | 15 | n/a |
| Jul 31, 2024 | 0.15 | 15 | -99.69% |
| May 24, 2024 | 0.17 | 4.9K | +969.65% |
| Apr 30, 2024 | 0.2451 | 458 | +100.88% |
| Mar 28, 2024 | 0.42 | 228 | +46.15% |
| Feb 22, 2024 | 0.38 | 156 | +1014.29% |
| Jan 22, 2024 | 0.20 | 14 | +180.00% |
| Dec 11, 2023 | 0.09 | 5 | -95.76% |
| Nov 30, 2023 | 0.25 | 118 | +68.57% |
| Sep 26, 2023 | 0.13 | 70 | -30.00% |
| Aug 14, 2023 | 0.15 | 100 | -90.91% |
| Jul 14, 2023 | 0.28 | 1.1K | +80.62% |
| Jun 06, 2023 | 0.3 | 609 | +547.87% |
| May 31, 2023 | 0.25 | 94 | +1075.00% |
| Apr 27, 2023 | 0.30 | 8 | -99.43% |
| Mar 24, 2023 | 0.34 | 1.4K | +131.02% |
| Feb 27, 2023 | 0.52 | 606 | +12020.00% |
| Jan 30, 2023 | 0.2901 | 5 | n/a |